Volkow: Thank you very much. Thanks for having me and have a nice day.
Barr: You, too.
Collision of the COVID-19 and Addiction Epidemics, Ann Intern Med, 2020 Jul 7; 173(1): 61-62. doi: 10.7326/M20-1212. Epub 2020 Apr 2.
Increased risk of COVID-19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States, World Psychiatry, 2021 Feb; 20(1): 124-130. doi: 10.1002/wps.20806. Epub 2020 Oct 7.
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States, Mol Psychiatry, 2021 Jan; 26(1): 30-39. doi: 10.1038/s41380-020-00880-7. Epub 2020 Sep 14.
Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States, Mol Psychiatry, 2021 Jan; 26(1): 40. doi: 10.1038/s41380-020-00895-0.
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19, JAMA Psychiatry, 2020 Sep 1. doi: 10.1001/jamapsychiatry.2020.3177. Online ahead of print.
The Healthy Brain and Child Development Study-Shedding Light on Opioid Exposure, COVID-19, and Health Disparities, JAMA Psychiatry, 2021 May 1; 78(5): 471-472. doi: 10.1001/jamapsychiatry.2020.3803.
Research on substance use disorders during the COVID-19 pandemic, J Substan Abuse Treat, 2021 Oct; 129: 108385. doi: 10.1016/j.jsat.2021.108385. Epub 2021 Apr 8.
Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021, World Psychiatry, 2021 Oct 5. doi: 10.1002/wps.20921. Online ahead of print.